Genentech, Lilly Fail to Meet Primary Endpoint in Alzheimer’s Trial

Genentech, Lilly Fail to Meet Primary Endpoint in Alzheimer's Trial

Will Biogen’s Stock Soar or Implode on Alzheimer’s Data?

Will Biogen's Stock Soar or Implode on Alzheimer's Data?

Research Roundup: Dog Ownership, Diabetes, Alzheimer’s, HIV Vaccine and More

Research Roundup: Dog Ownership, Diabetes, Alzheimer’s, HIV Vaccine and More

Research Roundup: Gum Disease and Alzheimer’s, a Cancer Vaccine, Cold Plasma and More

Research Roundup: Gum Disease and Alzheimer’s, a Cancer Vaccine, Cold Plasma and More

Axovant reaps the rewards from its gene therapy refocus

Axovant reaps the rewards from its gene therapy refocus

Researchers Identify New Genes That Could Play Key Role in Development of Alzheimer’s

Researchers Identify New Genes That Could Play Key Role in Development of Alzheimer’s

Λεπτό έντερο: Ένοχο για τα αυτοάνοσα νοσήματα;

Λεπτό έντερο: Ένοχο για τα αυτοάνοσα νοσήματα;

Voyager and AbbVie Forge Another Neurodegenerative Therapy Collaboration Worth More Than $1 Billion

Voyager and AbbVie Forge Another Neurodegenerative Therapy Collaboration Worth More Than $1 Billion

Ten European Genomics Companies to Watch Out For

Ten European Genomics Companies to Watch Out For

Research Roundup: Rare Pediatric Cancer, Hibernating Hamsters, Prostate Cancer and More

Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!    Scientists May Have Found New Approach to Treating Rare Pediatric Tumors Researchers with The University of Texas MD Anderson Cancer Center published research in the journal Cancer Cell describing potential new approaches to treating malignant rhabdoid tumors (MRT). MRT is a rare pediatric cancer that currently …